Bausch Health will announce its third quarter 2024 results on October 30, 2024

LAVAL, QC / ACCESS WIRE / October 9, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will announce its third quarter 2024 financial results after market close on Wednesday, October 30, 2024. Bausch Health will host a conference call and live webcast at 5:00 PM US EST at discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.

Conference call details

A replay of the conference call will be available on the investor relations website.

To participate in the live Q&A session, register via this link. You will then receive an email confirming your registration with further details.

About Bausch Health

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company that enriches lives through our relentless pursuit of better healthcare outcomes. We develop, produce and sell a range of products primarily in the areas of gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals and eye health, through our majority stake in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, healthcare providers, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.

###

SOURCE: Bausch Health Companies Inc.

View the original press release on accesswire.com